Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2026-02-18 @ 10:09 AM
Study NCT ID:
NCT04091750
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-25
First Post:
2019-09-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma
Sponsor:
Georgetown University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
STUDY00000904
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None